Janney Montgomery Scott LLC Grows Holdings in The Clorox Company $CLX

Janney Montgomery Scott LLC boosted its stake in The Clorox Company (NYSE:CLX) by 48.1% in the 1st quarter, according to its most recent filing with the SEC. The fund owned 163,848 shares of the company’s stock after purchasing an additional 53,209 shares during the period. Janney Montgomery Scott LLC’s holdings in Clorox were worth $16,980,000 at the end of the most recent quarter.

A number of other institutional investors and hedge funds also recently added to or reduced their stakes in the company. Haverford Trust Co boosted its position in shares of Clorox by 2.8% during the fourth quarter. Haverford Trust Co now owns 3,070 shares of the company’s stock worth $310,000 after buying an additional 84 shares during the period. Field & Main Bank raised its holdings in shares of Clorox by 3.3% in the 4th quarter. Field & Main Bank now owns 3,100 shares of the company’s stock valued at $313,000 after buying an additional 100 shares during the period. Golden State Wealth Management LLC lifted its stake in Clorox by 28.2% during the 4th quarter. Golden State Wealth Management LLC now owns 454 shares of the company’s stock worth $46,000 after acquiring an additional 100 shares in the last quarter. Fisher Asset Management LLC lifted its stake in Clorox by 1.7% during the 3rd quarter. Fisher Asset Management LLC now owns 6,053 shares of the company’s stock worth $746,000 after acquiring an additional 102 shares in the last quarter. Finally, Kestra Private Wealth Services LLC boosted its holdings in Clorox by 1.8% during the 1st quarter. Kestra Private Wealth Services LLC now owns 5,957 shares of the company’s stock valued at $617,000 after acquiring an additional 104 shares during the period. Hedge funds and other institutional investors own 78.53% of the company’s stock.

Analysts Set New Price Targets

CLX has been the topic of a number of recent research reports. Citigroup cut their price target on shares of Clorox from $110.00 to $97.00 and set a “neutral” rating on the stock in a research note on Friday, May 1st. Barclays dropped their price objective on shares of Clorox from $102.00 to $85.00 and set an “underweight” rating for the company in a report on Friday, May 1st. TD Cowen upped their target price on shares of Clorox from $98.00 to $111.00 and gave the stock a “hold” rating in a research note on Tuesday, March 31st. Morgan Stanley reduced their target price on shares of Clorox from $110.00 to $97.00 and set an “equal weight” rating on the stock in a report on Friday, May 1st. Finally, UBS Group decreased their price target on shares of Clorox from $110.00 to $96.00 and set a “neutral” rating for the company in a research report on Friday, May 1st. One analyst has rated the stock with a Buy rating, eleven have given a Hold rating and five have given a Sell rating to the company. According to MarketBeat.com, the company has an average rating of “Reduce” and a consensus target price of $103.40.

Clorox Stock Down 1.9%

CLX stock opened at $95.29 on Wednesday. The company’s 50 day moving average price is $94.38 and its 200 day moving average price is $104.37. The firm has a market capitalization of $11.52 billion, a price-to-earnings ratio of 15.47, a PEG ratio of 0.50 and a beta of 0.56. The Clorox Company has a fifty-two week low of $84.70 and a fifty-two week high of $132.03. The company has a debt-to-equity ratio of 27.03, a quick ratio of 0.65 and a current ratio of 0.84.

Clorox (NYSE:CLX) last issued its quarterly earnings results on Thursday, April 30th. The company reported $1.64 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $1.55 by $0.09. Clorox had a net margin of 11.18% and a return on equity of 443.64%. The company had revenue of $1.67 billion during the quarter, compared to the consensus estimate of $1.67 billion. During the same quarter in the previous year, the firm earned $1.45 earnings per share. The firm’s quarterly revenue was up .1% on a year-over-year basis. Clorox has set its FY 2026 guidance at 5.450-5.650 EPS. On average, equities research analysts anticipate that The Clorox Company will post 5.61 EPS for the current fiscal year.

Insider Activity

In other news, Director Pierre R. Breber acquired 5,000 shares of the firm’s stock in a transaction dated Tuesday, May 5th. The stock was acquired at an average cost of $85.82 per share, with a total value of $429,100.00. Following the transaction, the director owned 18,000 shares in the company, valued at approximately $1,544,760. This trade represents a 38.46% increase in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which can be accessed through this hyperlink. Company insiders own 0.63% of the company’s stock.

About Clorox

The Clorox Company is a leading manufacturer and marketer of consumer and professional products designed to help people care for their homes and live healthy, sustainable lives. Its portfolio spans cleaning and household products, food and beverages, water filtration systems and cat litter, serving both retail and institutional customers. The company’s flagship bleach and disinfecting products are well known in the United States and many international markets, where they help prevent the spread of germs in homes, hospitals, schools and businesses.

Clorox’s diverse brand lineup includes liquid bleach and surface cleaners, eco-friendly cleaning tools, food preservation and preparation items, charcoal grills and briquettes, specialty foods and beverages, pet care products and personal care lines.